- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03397784
IVC Variation After VT Challenge to Predict Fluid Responsiveness
February 1, 2018 updated by: Shanghai Zhongshan Hospital
Can Respiratory Variation in Inferior Vena Cava Diameter After Tidal Volume Challenge Predict Fluid Responsiveness in Cardiac Surgical Patients With Mechanical Ventilation
The purpose of the study was to evaluate the efficacy of using the respiratory variation in inferior vena cava diameters as an index of fluid responsiveness after tidal volume challenge in mechanically ventilated patients after cardiac surgery.
Study Overview
Status
Unknown
Detailed Description
The "tidal volume challenge" is a novel test to predict fluid responsiveness in patents in shock, ventilated using low tidal volume without spontaneous breathing activity.
The test involves transiently increasing tidal volume from 8 ml/kg PBW to 12 ml/kg PBW for one minute and observing the change in PPV or SVV.
The aim of this study was to evaluate whether the respiratory variation in inferior vena cava diameter after tidal volume challenge can predict fluid responsiveness in cardiac surgical patients with mechanical ventilation
Study Type
Observational
Enrollment (Anticipated)
70
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Shanghai, China, 200032
- Recruiting
- Zhongshan hospital, Fudan university
-
Contact:
- Luo Zhe, PhD
- Phone Number: 3659 +86-21-64041990
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients after cardiac surgery
Description
Inclusion Criteria:
- acute circulatory failure (low blood pressure or urine output, tachycardia, or mottling)
- clinical signs of organ hypoperfusion (renal dysfunction or hyperlactatemia)
Exclusion Criteria:
- a contraindication to elevation of tidal volume
- evidence of cardiac arrhythmia
- left ventricular ejection fraction less than 50%
- echocardiographic examination that showed the existence of severe tricuspid or mitral regurgitation or right heart dysfunction
- intracardiac shunt
- pulmonary hypertension
- severe chronic obstructive pulmonary disease
- a contraindication to the passive leg raising (PLR) test
- air leakage through chest drains
- abdominal compartment syndrome
- portal hypertension
- pregnancy
- inability to perform ultrasonography
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
fluid responders
Patients whose stroke volume index increase by ≥15% in response to a 500-ml fluid bolus was defined as fluid responders.
|
|
fluid non-responders
Patients whose stroke volume index increase by <15% in response to a 500-ml fluid bolus was defined as fluid non-responders.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
fluid responsiveness
Time Frame: after fluid challenge (30min)
|
Patients will be classified as "fluid responders" if there is an increase in SV ≥15% after the fluid challenge, and the remaining patients are classified as "fluid non-responders"
|
after fluid challenge (30min)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
inferior vena cava variation
Time Frame: After tidal volume challenge (1 minute) and fluid challenge (30 minute)
|
Ultrasound equipment with convex probe will be used to measure IVC diameters of the patients in supine position.The IVC sagittal section is described with the probe in the area of subxiphoid.
IVC diameters at the junction point of the IVC and right atrium (2cm caudal) are standardized measurement.
The maximum anterior-posterior dimension came out from end-inspiration (IVCi, mm), whereas the minimum IVC diameter was shown in end-expiration (IVCe, mm).
The IVC variation (IVCV) is calculated using the formula: IVCV (%) = (IVCi - IVCe) / [(IVCi+ IVCe) / 2] ×100%.
|
After tidal volume challenge (1 minute) and fluid challenge (30 minute)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tu Guo-wei, PhD, Fudan University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
February 3, 2018
Primary Completion (ANTICIPATED)
December 31, 2019
Study Completion (ANTICIPATED)
December 31, 2019
Study Registration Dates
First Submitted
January 1, 2018
First Submitted That Met QC Criteria
January 11, 2018
First Posted (ACTUAL)
January 12, 2018
Study Record Updates
Last Update Posted (ACTUAL)
February 5, 2018
Last Update Submitted That Met QC Criteria
February 1, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- VIVC-TVC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.